109 related articles for article (PubMed ID: 8529197)
21. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
Rokhlin OW; Bishop GA; Hostager BS; Waldschmidt TJ; Sidorenko SP; Pavloff N; Kiefer MC; Umansky SR; Glover RA; Cohen MB
Cancer Res; 1997 May; 57(9):1758-68. PubMed ID: 9135020
[TBL] [Abstract][Full Text] [Related]
22. Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants.
Wright SC; Zheng H; Zhong J; Torti FM; Larrick JW
J Cell Biochem; 1993 Nov; 53(3):222-33. PubMed ID: 8263039
[TBL] [Abstract][Full Text] [Related]
23. [Effect of tyrosine kinase and tyrosine phosphatase inhibitors on ATP- and thapsigargin-induced CA2+ entry in rat peritoneal macrophages].
Krutetskaia ZI; Levedev OE; Tiushev VE; Krutetskaia NI; Roshchina NG
Tsitologiia; 1997; 39(2-3):164-76. PubMed ID: 9312907
[TBL] [Abstract][Full Text] [Related]
24. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine.
Desai RK; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324
[TBL] [Abstract][Full Text] [Related]
25. Preferential requirement for protein tyrosine phosphatase activity in the 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of human colon cancer cells.
Kuo ML; Huang TS; Lin JK
Biochem Pharmacol; 1995 Oct; 50(8):1217-22. PubMed ID: 7488237
[TBL] [Abstract][Full Text] [Related]
26. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
27. Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation.
Silvy M; Martin PM; Chajry N; Berthois Y
Endocrinology; 1998 May; 139(5):2382-91. PubMed ID: 9564849
[TBL] [Abstract][Full Text] [Related]
28. Okadaic acid, a serine/threonine phosphatase inhibitor, induces tyrosine dephosphorylation/inactivation of protein kinase FA/GSK-3 alpha in A431 cells.
Yu JS; Yang SD
J Biol Chem; 1994 May; 269(20):14341-4. PubMed ID: 7514166
[TBL] [Abstract][Full Text] [Related]
29. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3.
Suzuki K; Koike H; Matsui H; Ono Y; Hasumi M; Nakazato H; Okugi H; Sekine Y; Oki K; Ito K; Yamamoto T; Fukabori Y; Kurokawa K; Yamanaka H
Int J Cancer; 2002 Jun; 99(6):846-52. PubMed ID: 12115487
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative and apoptosis-inducing effects of an antitumor glycoprotein from Streptococcus pyogenes.
Yoshida J; Takamura S; Ishibashi T; Nishio M
Anticancer Res; 1999; 19(3A):1865-71. PubMed ID: 10470129
[TBL] [Abstract][Full Text] [Related]
31. Modulation of cell adhesion by tyrosine kinases and phosphatases inhibitors.
Stefănescu M; Matache C; Onu A; Szegli G
Roum Arch Microbiol Immunol; 1997; 56(1-2):3-15. PubMed ID: 9558971
[TBL] [Abstract][Full Text] [Related]
32. Genistein inhibits Ca2+ influx by extracellular ATP in PC12 pheochromocytoma cells.
Kozawa O; Shinoda J; Suzuki A
Horm Metab Res; 1995 Jun; 27(6):272-4. PubMed ID: 7557837
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
[TBL] [Abstract][Full Text] [Related]
34. Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6.
Mahmoud MS; Ishikawa H; Fujii R; Kawano MM
Blood; 1998 Nov; 92(10):3887-97. PubMed ID: 9808582
[TBL] [Abstract][Full Text] [Related]
35. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
36. Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
Rabinowich H; Lin WC; Herberman RB; Whiteside TL
J Immunol; 1994 Oct; 153(8):3504-13. PubMed ID: 7523496
[TBL] [Abstract][Full Text] [Related]
37. Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells.
Sheremet YA; Yemets AI; Azmi A; Vissenberg K; Verbelen JP; Blume YB
Tsitol Genet; 2012; 46(5):3-11. PubMed ID: 23342643
[TBL] [Abstract][Full Text] [Related]
38. Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2.
Amaral MC; Casillas AM; Nel AE
Immunology; 1993 May; 79(1):24-31. PubMed ID: 8389730
[TBL] [Abstract][Full Text] [Related]
39. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
40. RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1phase.
Hamaguchi T; Sudo T; Osada H
FEBS Lett; 1995 Sep; 372(1):54-8. PubMed ID: 7556642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
